Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

17.60
-0.6200-3.40%
Post-market: 17.770.1700+0.97%19:30 EDT
Volume:2.56M
Turnover:45.28M
Market Cap:1.57B
PE:-7.01
High:18.46
Open:18.46
Low:17.52
Close:18.22
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.69
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:104.09
PE(LYR):-5.34

Loading ...

Top US Stock Movers on August 14: Storage Sector Surge Powered by Micron and SanDisk

Deep News
·
Aug 14

Why great earnings haven't been good enough for AI hardware stocks

Morning Star AU
·
Aug 13

【US Pre-Market】Apple Downgraded, Berkshire Earnings in Focus; Commercial Space Stocks Rise as RKLB and ASTS Face Earnings Catalysts

TradingKey
·
Aug 10

Syndax Pharmaceuticals (SNDX) Stock Looks Stretched As Its 63% Run Continues

Simply Wall St.
·
Aug 09

U.S. Stocks Decline Midday Thursday as Traders Monitor Iran Tensions, Sandisk Drops 5%

Deep News
·
Aug 07

Nuvation Bio Q2 Revenue Beats Estimates on Ibtrozi Growth

Reuters
·
Aug 06

Syndax Grants Stock Option Awards for 59,250 Shares to Five New Employees

Reuters
·
Aug 06

Arcutis Q2 Revenue Rises on Demand for Zoryve, Lifts 2026 Sales Outlook

Reuters
·
Aug 06

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 06

UroGen Pharma Q2 Revenue Beats on Strong Zusduri Sales

Reuters
·
Aug 05

Syndax Pharmaceuticals, Inc. : Bofa Global Research Cuts Price Objective to $26 from $29

THOMSON REUTERS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Syndax Pharmaceuticals (SNDX) and DaVita (DVA)

TIPRANKS
·
Aug 05

Geron's Q2 Revenue Rises on Rytelo Growth

Reuters
·
Aug 05

Even Big Profits Aren't Enough to Keep Chip Investors Happy

Dow Jones
·
Aug 05

Syndax Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Syndax 1H FY26 Net Loss Narrows to $49.4 Million; 2Q FY26 Revenue Rises 92% to $72.8 Million

Reuters
·
Aug 05

Syndax Q2 Revenue Jumps 92% on Revuforj, Niktimvo Demand

Reuters
·
Aug 05

Syndax Pharmaceuticals Q2 EPS $(0.55) Misses $(0.49) Estimate, Sales $72.788M Miss $79.323M Estimate

Benzinga Earnings
·
Aug 05

Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million

Reuters
·
Aug 05

US Market Movers: Amazon Surges Over 15% on Strong Cloud Results, Apple Drops 7% on Component Constraints

Deep News
·
Aug 01